Compute Health Acquisition Corp. (CPUH) Shareholders Approve Allurion Deal

Compute Health (NYSE:CPUH) announced this afternoon that its shareholders approved its combination with weight-loss medtech firm Allurion at a special meeting held earlier today.

Approximately 99.8% of the votes cast on the business combination proposals by holders of Compute Health’s common stock, representing approximately 87.7% of the company’s outstanding common stock, voted to approve the deal, including approximately 58.2% of the outstanding shares of Class A common stock.

Although Compute Health has not yet disclosed redemption figures, the SPAC already saw 89.31% of its trust redeemed during an extension meeting in December. Nonetheless, the parties expect to close the deal on or about August 1, subject to the satisfaction of customary closing conditions.

Following the closing, the combined company will operate as Allurion Technologies, Inc. and will be listed on the NYSE, with its common stock and public warrants trading under the new ticker symbols “ALUR” and “ALUR WS,” respectively.

Today’s announcement follows yesterday’s approval from warrant holders to amend Compute Health’s warrant agreement. Compute Health inked its $500 million business combination with Allurion earlier this year in February. Natick, Massachusetts-based Allurion makes a swallowable balloon that inflates in patients’ stomachs to reduce space for incoming food for weight loss purposes while serving as an IoT tracker of certain health metrics.